Trade IGM Biosciences Inc - IGMS CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.07 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023679% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001457% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 1.12 |
| Open | 1.1 |
| 1-Year Change | -88.53% |
| Day's Range | 1.08 - 1.17 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 1, 2025 | 1.11 | -0.02 | -1.77% | 1.13 | 1.17 | 1.08 |
| Mar 31, 2025 | 1.12 | -0.01 | -0.88% | 1.13 | 1.15 | 1.09 |
| Mar 28, 2025 | 1.21 | -0.05 | -3.97% | 1.26 | 1.26 | 1.19 |
| Mar 27, 2025 | 1.24 | 0.06 | 5.08% | 1.18 | 1.27 | 1.18 |
| Mar 26, 2025 | 1.20 | -0.03 | -2.44% | 1.23 | 1.23 | 1.13 |
| Mar 25, 2025 | 1.22 | -0.01 | -0.81% | 1.23 | 1.23 | 1.16 |
| Mar 24, 2025 | 1.22 | 0.08 | 7.02% | 1.14 | 1.22 | 1.12 |
| Mar 21, 2025 | 1.16 | -0.02 | -1.69% | 1.18 | 1.18 | 1.11 |
| Mar 20, 2025 | 1.17 | -0.02 | -1.68% | 1.19 | 1.24 | 1.17 |
| Mar 19, 2025 | 1.23 | 0.05 | 4.24% | 1.18 | 1.24 | 1.15 |
| Mar 18, 2025 | 1.17 | 0.00 | 0.00% | 1.17 | 1.21 | 1.15 |
| Mar 17, 2025 | 1.19 | 0.00 | 0.00% | 1.19 | 1.21 | 1.13 |
| Mar 14, 2025 | 1.20 | 0.00 | 0.00% | 1.20 | 1.23 | 1.15 |
| Mar 13, 2025 | 1.25 | -0.11 | -8.09% | 1.36 | 1.37 | 1.22 |
| Mar 12, 2025 | 1.34 | -0.02 | -1.47% | 1.36 | 1.38 | 1.31 |
| Mar 11, 2025 | 1.34 | 0.06 | 4.69% | 1.28 | 1.38 | 1.25 |
| Mar 10, 2025 | 1.30 | 0.07 | 5.69% | 1.23 | 1.32 | 1.23 |
| Mar 7, 2025 | 1.28 | -0.01 | -0.78% | 1.29 | 1.32 | 1.22 |
| Mar 6, 2025 | 1.36 | 0.07 | 5.43% | 1.29 | 1.39 | 1.29 |
| Mar 5, 2025 | 1.31 | 0.02 | 1.55% | 1.29 | 1.33 | 1.27 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
IGM Biosciences, Inc. Company profile
About IGM Biosciences Inc
IGM Biosciences, Inc. is a biotechnology company engaged in the development of engineered IgM antibodies for the treatment of multiple diseases. It has developed an IgM antibody technology platform that is particularly well suited for developing T cell engagers, receptor cross-linking agonists and targeted cytokines. Its lead product candidate, IGM-2323, a bispecific T cell engaging IgM antibody targeting CD20 and CD3 proteins, is in an ongoing Phase I clinical trial for the treatment of relapsed/refractory B-cell non-Hodgkin’s lymphoma (NHL) patients. Its second product candidate, IGM-8444, is an IgM antibody targeting Death Receptor 5 (DR5) proteins, which is for the treatment of patients with solid and hematologic malignancies. The Company’s pipeline also includes IGM-7354, a bispecific IgM antibody delivering interleukin-15 (IL-15) cytokines to PD-L1 expressing cells for the treatment of patients with solid and hematologic malignancies.
Financial summary
BRIEF: For the nine months ended 30 September 2021, IGM Biosciences Inc revenues was not reported. Net loss increased from $56.7M to $114.5M. Higher net loss reflects Research and development - Bala increase of 89% to $80.3M (expense), General and administrative - Balanc increase of 67% to $17.1M (expense), Stock-based Compensation in SGA increase from $2.9M to $9.7M (expense).
| Industry: | Bio Therapeutic Drugs |
325 E Middlefield Rd
MOUNTAIN VIEW
CALIFORNIA 94043-4003
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com